November 05, 2025

Get In Touch

Lidocaine And Epinephrine Combo Reduces Blood Loss In Abdominal Myomectomy

Abdominal Myomectomy Study

Abdominal Myomectomy Study

During abdominal myomectomy, a combination of lidocaine and epinephrine appeared to be a safe and effective way to reduce blood loss, says an article published in Health Science Reports.

Abdominal myomectomy can produce significant intraoperative bleeding, which can lead to negative consequences. Uterine fibroid is a common benign pelvic tumor. As a result, Mandana Mansour-Ghanaei and colleagues undertook this study to see how efficient lidocaine with epinephrine injections are at reducing intraoperative bleeding during abdominal myomectomy.

60 women with uterine fibroids were included in a randomized controlled experiment between October 2019 and May 2020. All of the patients were randomly assigned to one of two groups: lidocaine with epinephrine (Group L) or placebo (Group P). Lidocaine 3 mg/kg + 0.5 ml adrenaline diluted to 50 cc with saline solution was utilized in group L, whereas 50 ml of normal saline was used in group P. Before incision, both the mixed solution and regular saline were injected into the serous and myometrium above and surrounding the fibroid. The demographic characteristics, total operating time, hemoglobin changes, and degree of surgical difficulties of the two groups were assessed and compared.

Key Findings

  • In terms of demographic statistics, there was no substantial difference between the two groups.
  • In comparison to Group P, hemoglobin alterations (p 0.0001) and the degree of operation difficulty (p = 0.01) were considerably lower in Group L.
  • The decline in hemoglobin levels from baseline to 4 hours postoperatively was considerable in each group (p 0.0001).
  • Hemoglobin alterations and the degree of surgical difficulties were shown to have a statistically significant relationship with uterine and fibroids size (p 0.05).
  • While there was a negative connection between gravidity and surgical difficulties (r = 0.413, p = 0.02), Surgery time was greater in Group P than in Group L (70.66±19.85 versus 66.16± 14.48, respectively), although the difference was not significant (p = 0.32).
  • In both groups, no notable adverse reactions or severe complications were recorded. Throughout the procedure, hemodynamic values were managed within normal limits.

In conclusion, the injection of a saline solution combining lidocaine and adrenaline in abdominal myomectomy was shown to be an effective and safe strategy in this investigation. More well-planned experiments with bigger sample sizes and more information are strongly advised for finding practical outcomes that can be generalized to a clinical context.

Reference

Mansour‐Ghanaei, M., Hosseinzadeh, F., Sharami, S. H., Biazar, G., Noori, F., & Asgari‐Ghalebin, S. M. (2022). Safety and efficacy of lidocaine plus epinephrine on intraoperative bleeding in abdominal myomectomy: A double‐blind clinical trial. In Health Science Reports (Vol. 5, Issue 2). Wiley. https://doi.org/10.1002/hsr2.551

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!